Key players in Amyloidosis Treatment
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 2 | Alnylam Pharmaceuticals | — | 66 reports |
| 3 | Ionis Pharmaceuticals | — | 132 reports |
| 4 | BridgeBio Pharma | — | 33 reports |
| 5 |  AstraZeneca |
astrazeneca.com (opens in a new tab) | 957 reports |
Also active in Amyloidosis Treatment
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Johnson & Johnson |
|
| Am Regent | |
| Alvogen | |
 Eli Lilly and Company |
|
 Bayer AG |
|
| Conba USA | |
| Eidos Therapeutics |
|
 Colgate Palmolive Mfg |
|
| Somerset Theraps LLC | |
| Foldrx Pharmaceuticals | |
 Novo Nordisk A/S |
|
| Intellia Therapeutics |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Amyloidosis Treatment
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- AstraZeneca 14 active trials on ClinicalTrials.gov (opens in a new tab)
- Eli Lilly and Company 9 active trials on ClinicalTrials.gov (opens in a new tab)
- Alnylam Pharmaceuticals 8 active trials on ClinicalTrials.gov (opens in a new tab)
- Bayer AG 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Eidos Therapeutics 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Colgate Palmolive Mfg 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Johnson & Johnson 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Novo Nordisk A/S 3 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Amyloidosis Treatment reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Amyloidosis Treatment report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.